In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
  • Year

    Select Year(s)

  • Session Type

    Select Session Type(s)

  • Resource type

    Select Resource type(s)

  • Topic

    Select Topic(s)

Filters (0)
  • sub-topic
  • Year
  • Session Type
  • Resource type
  • Topic
  • sub-topic
  • Year
  • Session Type
  • Resource type
  • Topic

6011 results for your search

2018

"HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism: D-Dimer inter-assay concordance

Congress : ESC Congress 2018

  • Session : Venous thrombosis and anticoagulation
  • Speaker : F Khan (Ottawa,CA)

Some member-only content

days left for free access
2018

"Health Buddy" apps as a tool to improve adherence in atrial fibrillation.

Congress : ESC Congress 2018

  • Session : Novel technology within cardiology - The role of the nurse
  • Speaker : L Desteghe (Hasselt,BE)

Some member-only content

days left for free access
2018

"Lone Atrial Fibrillation": definition and epidemiology.

Congress : ESC Congress 2018

  • Session : "Lone Atrial Fibrillation": should the concept be abandoned?
  • Speaker : I Deisenhofer (Munich,DE)
  • Joint with the Cardiac Society of Australia and New Zealand

Some member-only content

days left for free access
2018

"Multimodality echocardiograhy" to assess the rigth heart - State of the art

Congress : ESC Congress 2018

  • Session : Echocardiographic assessment of the right heart
  • Speaker : P Nihoyannopoulos (London,GB)

Some member-only content

days left for free access
2018

"No rule-out, no rule-in" of NSTE-ACS: what to do?

Congress : ESC Congress 2018

  • Session : The advantages and caveats of fast diagnostic algorithms for suspected NSTE-ACS
  • Speaker : C E Mueller (Basel,CH)

Some member-only content

days left for free access
2018

"Raiders of the lost wire".

Congress : ESC Congress 2018

  • Session : "Indiana Jones" in the cath lab: getting yourself out of trouble
  • Speaker : G Tirado Conte (Madrid,ES)

Some member-only content

days left for free access
2018

"Shock Team" approach and other new ideas in managing cardiogenic shock

Congress : ESC Congress 2018

  • Session : Expert Advice - Cardiogenic shock during an ICU night shift - preparing for the worst to get the best
  • Speaker : S Drakos (Cottonwood Heights, Salt Lake City,US)

Some member-only content

days left for free access
2018

'Real world' m-Health technology supported home-based cardiac rehabilitation - Are we there yet?

Congress : ESC Congress 2018

  • Session : Digital health in clinical practice
  • Speaker : M Varnfield (Brisbane,AU)

Some member-only content

days left for free access
2018

10 years of follow-up in carriers of a RyR2 pathogenic mutation with uncertain penetrance. What have we learned?

Congress : ESC Congress 2018

  • Session : Arrhythmogenic channelopathies
  • Speaker : ACL Cardenes Leon (Las Palmas De Gc,ES)

Some member-only content

days left for free access
2018

10-year outcomes from a randomized comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Congress : ESC Congress 2018

  • Session : Outcome of coronary stenting up to 10 years
  • Speaker : M Pareek (Faaborg,DK)

Some member-only content

days left for free access

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are